• KX2-391 Dihydrochloride: Redefining Dual-Targeted Translatio

  2026-05-01

  This article provides an advanced, evidence-driven exploration of KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) as a dual Src kinase and tubulin inhibitor, highlighting its unique mechanisms, translational opportunities, and strategic guidance for cross-domain researchers. Drawing on benchmark studies and clinical insight, we position KX2-391 dihydrochloride from APExBIO as a pivotal tool for oncology, virology, and neurotoxin research, while clarifying protocol best practices and future outlook.

• Tankyrase Inhibition Suppresses HCC via Hippo Pathway Modula

  2026-05-01

  This study reveals that G007-LK, a selective tankyrase 1/2 inhibitor, suppresses hepatocellular carcinoma (HCC) cell proliferation by downregulating YAP signaling through stabilization of AMOTL1/2 proteins. The findings provide mechanistic insight into the dual regulation of Wnt/β-catenin and Hippo pathways, highlighting new avenues for targeted liver cancer research.

• Amikacin (BAY416651): Precision in Antibiotic Resistance Res

  2026-04-30

  Amikacin (BAY416651) enables targeted, reproducible workflows in antibiotic resistance research—especially when tackling difficult pathogens and granuloma-associated infections. This article translates landmark delivery strategies and experimental best practices into actionable protocols for applied microbiology labs.

• Phenothiazines Boost Macrophage Antibacterial Defense via RO

  2026-04-30

  This study demonstrates that phenothiazines, including promethazine hydrochloride, significantly enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy. The findings highlight a promising host-directed therapeutic strategy against intracellular bacterial infections, with implications for inflammation and immune research.

• Clozapine in Prefrontal Circuitry: Beyond Receptor Pharmacol

  2026-04-29

  Explore how Clozapine, a leading atypical antipsychotic medication, shapes prefrontal cortical function through ERK1/2 and EGF receptor signaling. This article uniquely addresses the neurophysiological and metabolic ramifications for advanced schizophrenia research.

• G007-LK Tankyrase 1/2 Inhibitor: Mechanisms, Assay Impact, a

  2026-04-29

  Explore how G007-LK, a potent tankyrase 1/2 inhibitor, enables advanced modulation of the Wnt/β-catenin pathway and YAP signaling. This article delivers new insights on mechanism, assay design, and translational research value beyond existing coverage.

• Exo1: Selective Inhibitor for Exocytic Pathway Research

  2026-04-28

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is a potent, ARF1-specific inhibitor of the exocytic pathway, enabling unique mechanistic dissection of Golgi-to-ER membrane trafficking. Its rapid, BFA-distinct action aids high-specificity exocytosis assays in preclinical research. Exo1 is available from APExBIO as SKU B6876.

• ATRX Loss Sensitizes High-Grade Glioma to RTK/PDGFR Inhibito

  2026-04-28

  This study demonstrates that ATRX-deficient high-grade glioma cells are markedly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors, including multikinase agents like Sorafenib. The findings suggest that ATRX status could inform clinical trial design and therapeutic strategies for aggressive gliomas.

• Necrostatin-1: Defining the Future of RIP1 Kinase Pathway Re

  2026-04-27

  Explore the strategic deployment of Necrostatin-1 as a selective RIP1 kinase inhibitor, blending mechanistic insight with translational guidance for researchers advancing necroptosis-targeted therapies. This article bridges foundational cell death biology with validated protocols and clinical relevance, offering a visionary outlook on necroptosis research and its impact on inflammatory and degenerative disease models.

• Redefining Doxorubicin Hydrochloride: From Mechanism to Miti

  2026-04-27

  Explore how doxorubicin hydrochloride (Adriamycin HCl) advances cancer chemotherapy research, with a unique focus on emerging strategies to mitigate cardiotoxicity. This article synthesizes molecular insights and the latest evidence to inform safer, more effective experimental designs.

• SELENOK, CD36 Palmitoylation, and Microglial Aβ Clearance in

  2026-04-26

  This study unveils the mechanistic link between SELENOK-dependent CD36 palmitoylation and microglial amyloid-beta (Aβ) phagocytosis, highlighting a selenium-driven pathway that modulates Alzheimer’s disease (AD) progression. The findings provide a cellular and molecular framework for targeting selenoproteins in AD therapy and reinforce the value of thiol-specific protein labeling in redox neurobiology.

• Fluo-4 AM in Biomimetic Vision: Advanced Calcium Imaging for

  2026-04-25

  Explore how Fluo-4 AM, a leading fluorescent calcium indicator, enables high-fidelity intracellular calcium concentration measurement in next-generation biomimetic vision research. This article uniquely connects assay optimization with the demands of artificial retinal prosthesis development.

• Naloxone Hydrochloride: Protocol Optimization for Opioid Res

  2026-04-24

  Naloxone hydrochloride from APExBIO enables precise, high-purity antagonism of opioid receptors for reproducible in vitro and in vivo studies. Explore advanced workflows, troubleshooting strategies, and the latest evidence on neural stem cell modulation and addiction research.

• Phosphatase Inhibitor Cocktail 2: Ensuring Phosphorylation I

  2026-04-24

  Discover how Phosphatase Inhibitor Cocktail 2 safeguards protein phosphorylation for advanced signaling studies, with a unique focus on stress-induced mitochondrial injury and assay rigor. Explore scientific mechanisms, comparative insights, and practical workflow guidance.

• Necrostatin-1: RIP1 Kinase Inhibitor Workflows & Optimizatio

  2026-04-23

  Necrostatin-1 is the gold-standard RIP1 kinase inhibitor for dissecting necroptosis, with robust applications in acute injury and inflammation research. This article delivers scenario-driven protocols, troubleshooting strategies, and translational insights to maximize reproducibility and impact with APExBIO's trusted Nec-1.

14510 records 1/968 page Next 12345 下5页 Last page